Daniel Loeb - Third Point
Holding/activity history for Elevance Health, Inc. (ELV)
← All ELV superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q2 | 0 | 0.00 | Sell 100.00% | 1.47 | $217.49–246.82 · VW $231.87i | SEC | |
| 2018 Q1 | 785,000 | 1.47 | Add 109.33% | 0.77 | $215.52–267.95 · VW $236.06i | $172,464,000 | SEC |
| 2017 Q4 | 375,000 | 0.70 | Reduce 70.00% | 1.56 | $182.31–236.39 · VW $217.58i | $84,379,000 | SEC |
| 2017 Q3 | 1,250,000 | 2.23 | $189.88 | $237,350,000 | SEC | ||
| 2017 Q2 | 1,250,000 | 2.08 | Add 8.70% | 0.17 | $163.87–194.94 · VW $182.27i | $235,162,000 | SEC |
| 2017 Q1 | 1,150,000 | 1.87 | Add 15.00% | 0.24 | $140.50–170.79 · VW $159.19i | $190,187,000 | SEC |
| 2016 Q4 | 1,000,000 | 1.41 | Buy | 1.41 | $114.85–148.26 · VW $132.89i | $143,770,000 | SEC |
Price snapshot:
Current price$425.17
52-week low$268.08
52-week high$427.64